ResveratrolanimalAnimal model2015

Stability of trans-resveratrol associated with transport proteins.

Journal of agricultural and food chemistry

confidence

Key findings

Both beta-lactoglobulin and human serum albumin protect trans-resveratrol from photoisomerization; albumin more effective than beta-lactoglobulin.

View source on PubMed (PMID 24773207) ↗

Sample size
N/A
Population
In vitro (spectroscopy and computational study)
Dosing
N/A
Duration
2 h irradiation
Route
N/A
Blinding
not_reported
Controls
none
Drug class
polyphenol
Full abstract

Spectrophotometry and fluorescence combined with docking and molecular dynamics simulations are used to study the effect of the carrier proteins β-lactoglobulin and human serum albumin on the degradative trans-to-cis conversion of resveratrol. The spectroscopic measurements quantify the concentration of resveratrol isoforms after 2 h of irradiation with light at 340 nm, showing that their ratio depends linearly on temperature between 20 and 50 °C and obeys an Arrhenius law with activation energies of photoisomerization of 7.8 and 11.2 kcal/mol for β-lactoglobulin and albumin, respectively, compared to 5.1 kcal/mol in solution. Thus, both proteins protect trans-resveratrol from degradation, with albumin being more effective than β-lactoglobulin. The computational techniques clarify details of the binding of trans-resveratrol to the proteins and show that the stabilizing effect correlates with an increase of the dihedral order parameter of the ligand. These findings suggest that transport proteins are viable carriers to stabilize and deliver resveratrol in vivo in the biologically effective trans form.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.